A groundbreaking scientific method allows to detect lung cancer through a blood test, eliminating the traditional and invasive biopsies. This technique results in an investigation made in the USA, with the honors of publication in the Journal of Science Medicine.
It is possible to dispense with biopsies and detect lung cancer via a blood test. Through a new technique, the disease can be unmasked in a simpler way.
Researchers analyzed 143 patients, all of whom had lung nodules, some of which are benign, others stage cancer.
Subsequently, there was a demand for 13 proteins present in blood, this method being able to detect cases of lung cancer efficacy with a very high percentage: 90 percent.
This paper was published in Science Journal of Medicine emphasizes that this type of cancer, the most common and fatal disease in the world.
“This technology, when applied to a protein assay of commercial speech, will have a tremendous interest to pulmonologists,” said Albert Luderer, executive of Integrated Diagnostics, which patented the technology.
were involved in this study researchers Langone Medical Center, New York University and School of Medicine, Perelman School of Medicine at the University of Pennsylvania and Vanderbilt University Medical Center.
In Portugal, estimated to die each year, 3000 Portuguese, victims of this disease. Every year 3,500 new cases are diagnosed. Early diagnosis and anti-smoking measures attempt to counter this reality.
 |
No comments:
Post a Comment